SGE-201
SGE-201 je agonist NMDA receptora.[3]
![(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-5-hidroksi-5-metilheksan-2-il]-10,13-dimetil-2,3,4,7,8,9,11,12,14,15,16,17-dodekahidro-1H-ciklopenta[a]fenantren-3-ol](/wiki/%D0%94%D0%B0%D1%82%D0%BE%D1%82%D0%B5%D0%BA%D0%B0:26,27-Dinorergost-5-ene-3,24-diol,_(3beta)-.png)
| |
| Nazivi | |
|---|---|
| IUPAC naziv
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-5-hidroksi-5-metilheksan-2-il]-10,13-dimetil-2,3,4,7,8,9,11,12,14,15,16,17-dodekahidro-1H-ciklopenta[a]fenantren-3-ol
| |
| Identifikacija | |
3D model (Jmol)
|
|
| |
| Svojstva | |
| C26H44O2 | |
| Molarna masa | 388,64 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
| Reference infokutije | |
Reference
уреди- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.
